AI assistant
Sending…
Silo Pharma, Inc. — Director's Dealing 2024
Nov 22, 2024
35304_dirs_2024-11-22_6875e91b-d9c0-4250-949e-6a896f9c077a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Silo Pharma, Inc. (SILO)
CIK: 0001514183
Period of Report: 2024-11-20
Reporting Person: Weisblum Eric (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-20 | Common Stock | P | 2500 | $0.95 | Acquired | 182932 | Direct |
| 2024-11-22 | Common Stock | P | 2500 | $0.90 | Acquired | 185432 | Direct |
More from Silo Pharma, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 14
Annual Report
2026
Mar 27
Regulatory Filings
2026
Feb 23
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2025
Dec 29
Director's Dealing
2025
Dec 17
Regulatory Filings
2025
Nov 28